https://pages.htgaa.org/2026b/jennifer-zayetsy-almeyda-tejada-almeyda/index.htmlAbout me Contact info Homework, Labs, and Projects See the nav bar on the left to look through my work for How To Biomanufacture Almost Anything (Fall 2026)!Hugoenhttps://pages.htgaa.org/2026b/jennifer-zayetsy-almeyda-tejada-almeyda/week-01-hw-project-ideas/index.htmlMon, 01 Jan 0001 00:00:00 +0000https://pages.htgaa.org/2026b/jennifer-zayetsy-almeyda-tejada-almeyda/week-01-hw-project-ideas/index.htmlAI-guided dynamic engineering of CHO cells for bispecific antibody biomanufacturing Jennifer Zayetsy Almeyda Tejada 1. What would I like to biomanufacture and why? My interest in biomanufacturing comes from both my personal experiences and my previous work with cell-based therapies. During college, I became interested in gene therapies, immunotherapies, and the possibility of engineering cells for therapeutic purposes. I later worked at V&C Biotech in Peru, a biotechnology company developing cell-based regenerative therapies, including applications for burn injuries. I was responsible for research and development, which gave me a lot of independence but also made me realize how much more I wanted to learn. Beyond developing the research itself, I became familiar with some of the requirements involved in producing cell-based therapies under controlled conditions, including clean-room environments and standardized manufacturing processes.https://pages.htgaa.org/2026b/jennifer-zayetsy-almeyda-tejada-almeyda/week-03-cell-free-reaction-design/index.htmlMon, 01 Jan 0001 00:00:00 +0000https://pages.htgaa.org/2026b/jennifer-zayetsy-almeyda-tejada-almeyda/week-03-cell-free-reaction-design/index.htmlLiterature-guided design and optimization of cell-free reaction formulations Jennifer Zayetsy Almeyda Tejada 1. Objective The goal of this project is to design 20-µL cell-free protein synthesis (CFPS) reactions for sfGFP, PETase/TfCut2, and Reteplase that reduce reagent cost while maintaining or improving production of functional protein. The three targets provide an increasing challenge in folding: sfGFP is a robust reporter with no disulfide bond, TfCut2 contains one disulfide bond, and Reteplase contains nine disulfide bonds and therefore requires substantially stronger control of the oxidative folding environment.https://pages.htgaa.org/2026b/jennifer-zayetsy-almeyda-tejada-almeyda/final-project/index.htmlMon, 01 Jan 0001 00:00:00 +0000https://pages.htgaa.org/2026b/jennifer-zayetsy-almeyda-tejada-almeyda/final-project/index.htmlhttps://pages.htgaa.org/2026b/jennifer-zayetsy-almeyda-tejada-almeyda/week-02-hw-dna-design/index.htmlMon, 01 Jan 0001 00:00:00 +0000https://pages.htgaa.org/2026b/jennifer-zayetsy-almeyda-tejada-almeyda/week-02-hw-dna-design/index.html